<DOC>
	<DOCNO>NCT00772031</DOCNO>
	<brief_summary>The purpose study compare reduction number severe headache day six month people chronic migraine treat topiramate propranolol versus treat topiramate placebo .</brief_summary>
	<brief_title>NINDS CRC Chronic Migraine Treatment Trial</brief_title>
	<detailed_description>Chronic migraine affect 2 percent adult . Currently effective preventative treatment deal disable condition . Three randomized , placebo-controlled trial find topiramate effective , safe generally well-tolerated drug treat chronic migraine . As result trial , topiramate become standard treatment among headache specialist . Experts agree treatment combination preventive agent require majority individual chronic migraine maximal headache relief . No randomized trial assess value frequently use combination preventive agent chronic migraine . The goal trial determine add second drug topiramate treatment reduce headache burden people condition . In study , 250 participant chronic migraine randomize two group - treatment topiramate propranolol topiramate placebo . Participants follow six month .</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<criteria>History chronic migraine least 6 month Age â‰¥ 18 year age migraine onset 60 young EKG perform last 12 month Prior neuroimaging suggest secondary structural cause headache Beck Depression Inventory FastScreen score 13 great severe psychiatric disorder Contraindication prior intolerance topiramate propranolol ( history sinus bradycardia , heart block , heart failure , diabetes prone hypoglycemia , asthma , kidney stone ) History kidney failure nephrolithiasis A female currently pregnant lactate plan become pregnant next year , childbearing potential practicing acceptable form birth control Currently require butalbital opioid drug acute headache treatment 10 day month Failure prior trial least 50 mg topiramate combine least 80 mg propranolol Use migraine preventive drug ( Medications grade group 1 , 2 , 3 , 4 AAN Evidencebased Guideline : valproate , divalproex sodium , gabapentin , amitriptyline , nortriptyline , protriptyline , betablocker , calcium channel blocker , cyproheptadine ; tizanidine ) within last two month receive botulinum toxin injection past 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>chronic migraine , migraine prevention , chronic headache</keyword>
</DOC>